BRT
Jump to navigation
Jump to search
Botanical Review Team of the Center for Drug Evaluation Research of the US Food and Drug Administration (FDA). BRT provides scientific expertise on botanical issues to CDER's reviewing staff and ensures consistent interpretation of FDA's "Guidance for Industry: Botanical Drug Products."
Also see
This is a short summary article. For quality control, we do not encourage or allow strangers to edit the content.